Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran for Fibromyalgia Brain Fog
NCT01108731Phase 3Completed
- Sponsor
- Mount Sinai Beth Israel
- Start
- Mar 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milnacipran in fibromyalgia (FM), sponsored by Mount Sinai Beth Israel. Started Mar 2010; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01108731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108731.